The First Affiliated Hospital with Nanjing Medical University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 563 studies whose lead sponsor is The First Affiliated Hospital with Nanjing Medical University. 311 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the The First Affiliated Hospital with Nanjing Medical University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Focus areas
Conditions The First Affiliated Hospital with Nanjing Medical University leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 563. Browse all 563 →
- Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II TrialRecruitingNCT07847710Phase 2
- Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System LymphomaNot yet recruitingNCT07888621Phase 2
- Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCLRecruitingNCT07884708Phase 2
- Study in Human iPSCs-derived RPE Cells Transplantation for Advanced (Late-stage) AMDRecruitingNCT07418177Phase 1/2
- Fufang Tongluo Decoction as an Adjunct to Aspirin and Atorvastatin for Ischemic Moyamoya DiseaseEnrolling by invitationNCT07875335Not applicable
- Real-World Study of BCL-2 Inhibitor-Based Regimens in Chronic Lymphocytic LeukemiaRecruitingNCT07874451
- A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) Combined With Cetuximab and mFOLFIRI Regimen as First-Line Treatment for Recurrent or Metastatic Colorectal CancerNot yet recruitingNCT07874438Not applicable
- Efficacy and Safety of Intraoperative Radiotherapy Combined With Serplulimab Plus Chemotherapy Versus Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07870798Phase 2
- Ear-Vagus Nerve Stimulation and Body Acupuncture for Gut Motility in Elderly ICU PatientsNot yet recruitingNCT07861503Not applicable
- A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic EncephalopathyNot yet recruitingNCT07612670
- Electronic PHES vs Paper-based PHES for Hepatic EncephalopathyNot yet recruitingNCT07852416Not applicable
- HER2-positive Breast Cancer Without Intravenous Neoadjuvant TherapyNot yet recruitingNCT07848633Phase 2
- Breast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized TrialRecruitingNCT07698366Not applicable
- Heart Rate Variability Changes and Postoperative Delirium After Major Abdominal SurgeryRecruitingNCT07783464
- Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel OcclusionRecruitingNCT07668323Phase 3
- Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic CancerNot yet recruitingNCT07831330Phase 2
- CT-AI Breast Cancer Opportunistic Screening Health Examination StudyNot yet recruitingNCT07809698Not applicable
- Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSFNot yet recruitingNCT07806084
- Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled TrialNot yet recruitingNCT07377981Phase 4
- ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPRNot yet recruitingNCT07799649
- Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract ReconstructionNot yet recruitingNCT07800819
- VA Dual Sequential TherapyRecruitingNCT06929962Phase 4
- RN1201 Injection for Autoimmune Diseases Refractory to Standard TherapiesRecruitingNCT07105735Phase 1
- Adjuvant Therapy for Potentially Immunotherapy-Responsive Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07772557Phase 2
- CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNot yet recruitingNCT07763938Phase 1
- A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic CancerRecruitingNCT07438106Phase 2
- The Efficacy of CAPCT in Patients With PTCLNot yet recruitingNCT07746245Phase 2
- Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal CancerRecruitingNCT04098471Not applicable
- Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy SurgeryRecruitingNCT06674187Not applicable
- Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II TrialRecruitingNCT07731828Phase 2
- Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)RecruitingNCT07719556Phase 2
- Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal CancerRecruitingNCT07718490Phase 2
- Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal MetastasisRecruitingNCT06543992Phase 2
- Neoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ AdenocarcinomaNot yet recruitingNCT07716111Phase 2
- Study on the Thrombolytic Effect of Platelet Membrane Coated Tenecteplase on Human Arterial ThrombusRecruitingNCT07712445
- SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric CancerRecruitingNCT07464756Phase 2
- Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA FragmentomicsNot yet recruitingNCT07684274
- A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)Not yet recruitingNCT07685236
- Dihydroartemisinin for MAFLDRecruitingNCT07679542Phase 1/2
- Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast CancerNot yet recruitingNCT07677956
- The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Depression in PDNot yet recruitingNCT07679529Not applicable
- A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL PatientsRecruitingNCT07671378Phase 2
- Prospective Cohort Study of Local Recurrence After Radical Breast Cancer ResectionNot yet recruitingNCT07668362
- An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract MalignanciesRecruitingNCT07668453Phase 2
- A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant TherapyNot yet recruitingNCT07669740Phase 2
- Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARCRecruitingNCT07646639Phase 2
- Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLNot yet recruitingNCT07643805Phase 1/2
- Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07628595Early Phase 1
- A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell MalignanciesNot yet recruitingNCT07628582Phase 1
- A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.RecruitingNCT07622836Not applicable